Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment

類似資料

• Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
  著者:: Kura, Klodeta, 等
  出版事項: (2021)
• Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration
  著者:: Kura, Klodeta, 等
  出版事項: (2020)
• Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
  著者:: Kura, Klodeta, 等
  出版事項: (2019)
• Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
  著者:: Toor, Jaspreet, 等
  出版事項: (2020)
• The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
  著者:: Kura, Klodeta, 等
  出版事項: (2020)